Prevalence and death rate of COVID-19 in some selected countries and its socio-economic impacts in Khulna division of Bangladesh

M. Sohidullah, Shahidur R. Khan, Ashiqul Alam, Nahid Rahman, Swarup K. Kundu, Arifur Rahman


Background: 2019-nCoV has been declared by WHO as a global pandemic in March 2020. The present study was undertaken to find out the global as well as local prevalence, and death rate of COVID-19.

Methods: A developed questionnaire was used in Khulna division of Bangladesh to record the percentages of people who were mask user, involved with different risk groups, harmed by socio-economic impacts of COVID-19, involved with the issue of government taking measures for controlling COVID-19. Some of the highly risk countries of the world were selected for recording the data.

Results: As of October 20, 2020, we found USA, and Bangladesh at 1st and 17th position respectively in terms of global prevalence of COVID-19. We found Dhaka at 1st position in terms of division wise prevalence in Bangladesh. In terms of death rate of COVID-19, Mexico reported 10.10% death rate by securing 1st position. We recorded the data related with percentages of people who were involved with mask using and risk groups like hypertension, diabetes, respiratory illness, smoking; harmed by socio-economic impacts of COVID-19 that changed their lives, believers of different levels on government taking measures for controlling the spread of COVID-19 from Khulna division.

Conclusions: The findings of this research work would certainly help the government of highly risk countries as well as Bangladesh to take appropriate measures to control COVID-19. Moreover, it will be helpful for the government of Bangladesh to take necessary steps to mitigate the socio-economic crises existing among the people.


COVID-19, SARS-CoV-2, WHO, Pandemic, Prevalence, Death rate

Full Text:



Kuri T, Eriksson KK, Putics A, Zust R, Snijder EJ. The ADP-ribose-1-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses. J Gen Virol. 2011;92(8):1899-1905.

Rahman MT, Sobur MA, Islam MS, Ievy S, Hossain MJ. El Zowalaty ME et al. Zoonotic Diseases: Etiology, Impact, and Control. Microorganisms. 2020;8(9):1405.

Martina BE, Haagmans BL, Kuiken T, Fouchier RA, Rimmelzwaan GF, Van Amerongen G et al. Virology: SARS virus infection of cats and ferrets. Nature. 2003;425(6961):915.

Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Sci. 2003;302(5643):276-8.

Paul R. Bangladesh confirms its first three cases of coronavirus. Retrieved. 2020;14:2020.

Mina FB, Billah M, Rahman MS, Das S, Karmakar S, Faruk M et al. COVID-19: transmission, diagnosis, policy intervention, and potential broader perspective on the rapidly evolving situation in Bangladesh. J Adv Biotechnol Exp Ther. 2020;3(4):18-29.

Bodrud-Doza M, Shammi M, Bahlman L, Islam ARMT, Rahman, MM. Psychosocial and socioeconomic crisis in Bangladesh due to COVID-19 pandemic: a perception-based assessment. Front Public Health. 2020;8:341.

Bhuiyan AKMI, Sakib N, Pakpour AH, Griffiths MD, Mamun MA. COVID-19-related suicides in Bangladesh due to lockdown and economic factors: case study evidence from media reports. Int J Ment Health Addict. 2020.

Islam MN. Islam AKMN. A systematic review of the digital interventions for fighting COVID-19: the Bangladesh perspective. IEEE Access. 2020;8:114078-87.

Hong KH, Lee SW, Kim TS, Huh HJ, Lee J, Kim SY. Guidelines for laboratory diagnosis of coronavirus disease 2019 (COVID-19) in Korea. Ann Lab Med. 2020;40(5):351-60.

Maier BF, Brockmann D. Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China. Sci. 2020;368(6492):742-6.

Worldometer. COVID-19 Coronavirus Pandemic, 2020. Available at https://www.worldometers. info/coronavirus/. Accessed on 20 October 2020.

Dashboard. Coronavirus COVID-19 Dashboard, 2020. Available at bd/webportal/pages/covid19.php. Accessed 20 October 2020.

Statista. Coronavirus (COVID-19) disease pandemic- Statistics and Facts, 2020. Available at Accessed 20 October 2020.

Sachs J, 2020. Why the US has the world's highest number of COVID-19 deaths. Available at Accessed 13 April 2020.

Ellis-Petersen H, 2020. India becomes country with second highest number of Covid cases. Available at Accessed 7 September 2020.

Bonetti G, Manelli F, Patroni A, Bettinardi A, Borrelli G, Fiordalisi G. Laboratory predictors of death from coronavirus disease 2019 (COVID) in the area of Valcamonica, Italy. Clin Chem Lab Med. 2020;58(7):1100-5.

Mostaza JM, García-Iglesias F, González-Alegre T, Blanco F, Varas M, Hernández-Blanco C. Clinical course and prognostic factors of COVID-19 infection in an elderly hospitalized population. Arch Gerontol Geriatr. 2020;91:104204.

Biswas S, 2020. Why India’s Covid problem could be bigger than we think. Available at Accessed 16 September 2020.

C CP, J Ghosh, 2020. COVID-19: Why is India doing worse than other South Asian countries? Available at Accessed 11 August 2020.

Mowla SG, Azad KA, Kabir A, Biswas S, Islam MR, Banik GC. Clinical profile of 100 confirmed COVID-19 patients admitted in dhaka medical college hospital, Dhaka, Bangladesh. J Bangladesh Coll Phys Surg. 2020;38(0):29-36.

Macintyre CR, Cauchemez S, Dwyer DE, Seale H, Cheung P, Browne G et al. Face mask use and control of respiratory virus transmission in households. Emerg Infect Dis. 2009;15(2):233-41.

Zhang L, Peng Z, Qu J, Zeng G, Fontaine RE, Liu M et al. Protection by face masks against influenza A (H1N1) pdm09 virus on trans-pacific passenger aircraft, 2009. Emerg Infect Dis. 2013;19(9):1403-10.

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531-8.

Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C et al. Diabetes is a risk factor for the progression and prognosis of COVID‐19. Diabetes Metab Res Rev. 2020;e3319.

Chen T, Wu D, Chen H, Yan W, Yang D, Chen G et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. Br Med J. 2020;368:m1295.

Deng Y, Liu W, Liu K, Fang YY, Shang J, Wang K et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study. Chin Med J. 2020;133(11):1261-7.

Zhao X, Zhang B, Li P, Ma C, Gu J, Hou P et al. Incidence clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. MedRxiv. 2020.

Odriozola-González P, Planchuelo-Gómez Á, Irurtia MJ, de Luis-García R. Psychological effects of the COVID-19 outbreak and lockdown among students and workers of a Spanish university. Psychiatry Res. 2020;290:113108.

Hwang TJ, Rabheru K, Peisah C, Reichman W, Ikeda, M. Loneliness and Social Isolation during the COVID-19 Pandemic. Int Psychogeriatr. 2020;32(10):1217-20.

Santini ZI, Jose PE, York Cornwell E, Koyanagi A, Nielsen L, Hinrichsen C et al. Social disconnectedness, perceived isolation, and symptoms of depression and anxiety among older Americans (NSHAP): A longitudinal mediation analysis. Lancet Public Health. 2020;5:e62-70.

Buheji M, Hassani S, Ebrahim A, Cunha C, Jahrami H, Baloshi M et al. Children and Coping During COVID-19: A Scoping Review of Bio-Psycho-Social Factors. Int J Appl Psychol. 2020;10(1):8-15.

Ibrahim A, Kabir N, Khan AK, Manzur SN, Reaz MM. To open or not to open: lockdown exit strategies can help. TBS News. 2020.

Hsu LY, Chia PY, Vasoo S. A midpoint perspective on the COVID-19 pandemic. Singapore Med J. 2020;61(7):381-3.

Siddika A, Islam MD. COVID-19 and Bangladesh: A study of the public perception on the measures taken by the government. 2020.